1 Supply Summary

• 1.1 Pathological Examination Introduction
• 1.2 World Pathological Examination Market Size & Forecast (2021 & 2025 & 2032)
• 1.3 World Pathological Examination Total Market by Region (by Headquarter Location)
  • 1.3.1 World Pathological Examination Market Size by Region (2021-2032), (by Headquarter Location)
  • 1.3.2 United States Based Company Pathological Examination Revenue (2021-2032)
  • 1.3.3 China Based Company Pathological Examination Revenue (2021-2032)
  • 1.3.4 Europe Based Company Pathological Examination Revenue (2021-2032)
  • 1.3.5 Japan Based Company Pathological Examination Revenue (2021-2032)
  • 1.3.6 South Korea Based Company Pathological Examination Revenue (2021-2032)
  • 1.3.7 ASEAN Based Company Pathological Examination Revenue (2021-2032)
  • 1.3.8 India Based Company Pathological Examination Revenue (2021-2032)
• 1.4 Market Drivers, Restraints and Trends
  • 1.4.1 Pathological Examination Market Drivers
  • 1.4.2 Factors Affecting Demand
  • 1.4.3 Major Market Trends

2 Demand Summary

• 2.1 World Pathological Examination Consumption Value (2021-2032)
• 2.2 World Pathological Examination Consumption Value by Region
  • 2.2.1 World Pathological Examination Consumption Value by Region (2021-2026)
  • 2.2.2 World Pathological Examination Consumption Value Forecast by Region (2027-2032)
• 2.3 United States Pathological Examination Consumption Value (2021-2032)
• 2.4 China Pathological Examination Consumption Value (2021-2032)
• 2.5 Europe Pathological Examination Consumption Value (2021-2032)
• 2.6 Japan Pathological Examination Consumption Value (2021-2032)
• 2.7 South Korea Pathological Examination Consumption Value (2021-2032)
• 2.8 ASEAN Pathological Examination Consumption Value (2021-2032)
• 2.9 India Pathological Examination Consumption Value (2021-2032)

3 World Pathological Examination Companies Competitive Analysis

• 3.1 World Pathological Examination Revenue by Player (2021-2026)
• 3.2 Industry Rank and Concentration Rate (CR)
  • 3.2.1 Global Pathological Examination Industry Rank of Major Players
  • 3.2.2 Global Concentration Ratios (CR4) for Pathological Examination in 2025
  • 3.2.3 Global Concentration Ratios (CR8) for Pathological Examination in 2025
• 3.3 Pathological Examination Company Evaluation Quadrant
• 3.4 Pathological Examination Market: Overall Company Footprint Analysis
  • 3.4.1 Pathological Examination Market: Region Footprint
  • 3.4.2 Pathological Examination Market: Company Product Type Footprint
  • 3.4.3 Pathological Examination Market: Company Product Application Footprint
• 3.5 Competitive Environment
  • 3.5.1 Historical Structure of the Industry
  • 3.5.2 Barriers of Market Entry
  • 3.5.3 Factors of Competition
• 3.6 Mergers & Acquisitions Activity

4 United States VS China VS Rest of World (by Headquarter Location)

• 4.1 United States VS China: Pathological Examination Revenue Comparison (by Headquarter Location)
  • 4.1.1 United States VS China: Pathological Examination Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
  • 4.1.2 United States VS China: Pathological Examination Revenue Market Share Comparison (2021 & 2025 & 2032)
• 4.2 United States Based Companies VS China Based Companies: Pathological Examination Consumption Value Comparison
  • 4.2.1 United States VS China: Pathological Examination Consumption Value Comparison (2021 & 2025 & 2032)
  • 4.2.2 United States VS China: Pathological Examination Consumption Value Market Share Comparison (2021 & 2025 & 2032)
• 4.3 United States Based Pathological Examination Companies and Market Share, 2021-2026
  • 4.3.1 United States Based Pathological Examination Companies, Headquarters (States, Country)
  • 4.3.2 United States Based Companies Pathological Examination Revenue, (2021-2026)
• 4.4 China Based Companies Pathological Examination Revenue and Market Share, 2021-2026
  • 4.4.1 China Based Pathological Examination Companies, Company Headquarters (Province, Country)
  • 4.4.2 China Based Companies Pathological Examination Revenue, (2021-2026)
• 4.5 Rest of World Based Pathological Examination Companies and Market Share, 2021-2026
  • 4.5.1 Rest of World Based Pathological Examination Companies, Headquarters (Province, Country)
  • 4.5.2 Rest of World Based Companies Pathological Examination Revenue (2021-2026)

5 Market Analysis by Type

• 5.1 World Pathological Examination Market Size Overview by Type: 2021 VS 2025 VS 2032
• 5.2 Segment Introduction by Type
  • 5.2.1 Histopathology
  • 5.2.2 Cytopathology
  • 5.2.3 Immunohistochemical Pathology
  • 5.2.4 Molecular Pathology
• 5.3 Market Segment by Type
  • 5.3.1 World Pathological Examination Market Size by Type (2021-2026)
  • 5.3.2 World Pathological Examination Market Size by Type (2027-2032)
  • 5.3.3 World Pathological Examination Market Size Market Share by Type (2027-2032)

6 Market Analysis by Application

• 6.1 World Pathological Examination Market Size Overview by Application: 2021 VS 2025 VS 2032
• 6.2 Segment Introduction by Application
  • 6.2.1 Hospital
  • 6.2.2 Medical Laboratory
• 6.3 Market Segment by Application
  • 6.3.1 World Pathological Examination Market Size by Application (2021-2026)
  • 6.3.2 World Pathological Examination Market Size by Application (2027-2032)
  • 6.3.3 World Pathological Examination Market Size Market Share by Application (2021-2032)

7 Company Profiles

• 7.1 Quest Diagnostics
  • 7.1.1 Quest Diagnostics Details
  • 7.1.2 Quest Diagnostics Major Business
  • 7.1.3 Quest Diagnostics Pathological Examination Product and Services
  • 7.1.4 Quest Diagnostics Pathological Examination Revenue, Gross Margin and Market Share (2021-2026)
  • 7.1.5 Quest Diagnostics Recent Developments/Updates
  • 7.1.6 Quest Diagnostics Competitive Strengths & Weaknesses
• 7.2 Sonic Healthcare
  • 7.2.1 Sonic Healthcare Details
  • 7.2.2 Sonic Healthcare Major Business
  • 7.2.3 Sonic Healthcare Pathological Examination Product and Services
  • 7.2.4 Sonic Healthcare Pathological Examination Revenue, Gross Margin and Market Share (2021-2026)
  • 7.2.5 Sonic Healthcare Recent Developments/Updates
  • 7.2.6 Sonic Healthcare Competitive Strengths & Weaknesses
• 7.3 Lab Corp
  • 7.3.1 Lab Corp Details
  • 7.3.2 Lab Corp Major Business
  • 7.3.3 Lab Corp Pathological Examination Product and Services
  • 7.3.4 Lab Corp Pathological Examination Revenue, Gross Margin and Market Share (2021-2026)
  • 7.3.5 Lab Corp Recent Developments/Updates
  • 7.3.6 Lab Corp Competitive Strengths & Weaknesses
• 7.4 Unilabs
  • 7.4.1 Unilabs Details
  • 7.4.2 Unilabs Major Business
  • 7.4.3 Unilabs Pathological Examination Product and Services
  • 7.4.4 Unilabs Pathological Examination Revenue, Gross Margin and Market Share (2021-2026)
  • 7.4.5 Unilabs Recent Developments/Updates
  • 7.4.6 Unilabs Competitive Strengths & Weaknesses
• 7.5 SYNLAB International
  • 7.5.1 SYNLAB International Details
  • 7.5.2 SYNLAB International Major Business
  • 7.5.3 SYNLAB International Pathological Examination Product and Services
  • 7.5.4 SYNLAB International Pathological Examination Revenue, Gross Margin and Market Share (2021-2026)
  • 7.5.5 SYNLAB International Recent Developments/Updates
  • 7.5.6 SYNLAB International Competitive Strengths & Weaknesses
• 7.6 BML
  • 7.6.1 BML Details
  • 7.6.2 BML Major Business
  • 7.6.3 BML Pathological Examination Product and Services
  • 7.6.4 BML Pathological Examination Revenue, Gross Margin and Market Share (2021-2026)
  • 7.6.5 BML Recent Developments/Updates
  • 7.6.6 BML Competitive Strengths & Weaknesses
• 7.7 Pathologists Diagnostic
  • 7.7.1 Pathologists Diagnostic Details
  • 7.7.2 Pathologists Diagnostic Major Business
  • 7.7.3 Pathologists Diagnostic Pathological Examination Product and Services
  • 7.7.4 Pathologists Diagnostic Pathological Examination Revenue, Gross Margin and Market Share (2021-2026)
  • 7.7.5 Pathologists Diagnostic Recent Developments/Updates
  • 7.7.6 Pathologists Diagnostic Competitive Strengths & Weaknesses
• 7.8 StageBio
  • 7.8.1 StageBio Details
  • 7.8.2 StageBio Major Business
  • 7.8.3 StageBio Pathological Examination Product and Services
  • 7.8.4 StageBio Pathological Examination Revenue, Gross Margin and Market Share (2021-2026)
  • 7.8.5 StageBio Recent Developments/Updates
  • 7.8.6 StageBio Competitive Strengths & Weaknesses
• 7.9 KingMed Diagnostics Group
  • 7.9.1 KingMed Diagnostics Group Details
  • 7.9.2 KingMed Diagnostics Group Major Business
  • 7.9.3 KingMed Diagnostics Group Pathological Examination Product and Services
  • 7.9.4 KingMed Diagnostics Group Pathological Examination Revenue, Gross Margin and Market Share (2021-2026)
  • 7.9.5 KingMed Diagnostics Group Recent Developments/Updates
  • 7.9.6 KingMed Diagnostics Group Competitive Strengths & Weaknesses
• 7.10 Dian Diagnostics Group
  • 7.10.1 Dian Diagnostics Group Details
  • 7.10.2 Dian Diagnostics Group Major Business
  • 7.10.3 Dian Diagnostics Group Pathological Examination Product and Services
  • 7.10.4 Dian Diagnostics Group Pathological Examination Revenue, Gross Margin and Market Share (2021-2026)
  • 7.10.5 Dian Diagnostics Group Recent Developments/Updates
  • 7.10.6 Dian Diagnostics Group Competitive Strengths & Weaknesses
• 7.11 Adicon Clinical Laboratories Inc.
  • 7.11.1 Adicon Clinical Laboratories Inc. Details
  • 7.11.2 Adicon Clinical Laboratories Inc. Major Business
  • 7.11.3 Adicon Clinical Laboratories Inc. Pathological Examination Product and Services
  • 7.11.4 Adicon Clinical Laboratories Inc. Pathological Examination Revenue, Gross Margin and Market Share (2021-2026)
  • 7.11.5 Adicon Clinical Laboratories Inc. Recent Developments/Updates
  • 7.11.6 Adicon Clinical Laboratories Inc. Competitive Strengths & Weaknesses
• 7.12 Huayin Health
  • 7.12.1 Huayin Health Details
  • 7.12.2 Huayin Health Major Business
  • 7.12.3 Huayin Health Pathological Examination Product and Services
  • 7.12.4 Huayin Health Pathological Examination Revenue, Gross Margin and Market Share (2021-2026)
  • 7.12.5 Huayin Health Recent Developments/Updates
  • 7.12.6 Huayin Health Competitive Strengths & Weaknesses

8 Industry Chain Analysis

• 8.1 Pathological Examination Industry Chain
• 8.2 Pathological Examination Upstream Analysis
• 8.3 Pathological Examination Midstream Analysis
• 8.4 Pathological Examination Downstream Analysis

9 Research Findings and Conclusion

10 Appendix

• 10.1 Methodology
• 10.2 Research Process and Data Source

The global Pathological Examination market size is expected to reach $ 72980 million by 2032, rising at a market growth of 9.8% CAGR during the forecast period (2026-2032).
Pathological examination is a medical diagnostic process that involves the analysis of tissues, cells, or bodily fluids to determine the nature, cause, and extent of disease. It includes techniques such as histopathology, cytology, immunohistochemistry, and molecular pathology. As the gold standard for diagnosing cancers and many other diseases, pathological examination plays a critical role in clinical decision-making, surgical planning, and prognosis assessment.
The pathological examination market is driven by the increasing global incidence of cancer and other chronic diseases that require tissue-based diagnosis. As healthcare systems shift toward precision medicine, the demand for accurate, early-stage diagnostic tools such as histopathology, cytology, and molecular pathology continues to rise. Technological advancements—such as digital pathology, immunohistochemistry (IHC), and next-generation sequencing (NGS)—have expanded the scope of pathology beyond traditional microscopy, improving workflow efficiency, diagnostic accuracy, and enabling personalized treatment strategies.
Despite strong growth potential, the pathological examination market faces key challenges including a shortage of trained pathologists, especially in developing countries. Manual workflow in traditional pathology can be time-consuming and error-prone, and digital pathology implementation requires significant infrastructure investment, standardization, and regulatory approval. Furthermore, variability in tissue sample quality, complex reimbursement environments, and integration issues with hospital information systems (HIS/LIS) continue to pose barriers to the widespread adoption of advanced pathology technologies.
This report studies the global Pathological Examination demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Pathological Examination, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pathological Examination that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Pathological Examination total market, 2021-2032, (USD Million)
Global Pathological Examination total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Pathological Examination total market, key domestic companies, and share, (USD Million)
Global Pathological Examination revenue by player, revenue and market share 2021-2026, (USD Million)
Global Pathological Examination total market by Type, CAGR, 2021-2032, (USD Million)
Global Pathological Examination total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Pathological Examination market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Quest Diagnostics, Sonic Healthcare, Lab Corp, Unilabs, SYNLAB International, BML, Pathologists Diagnostic, StageBio, KingMed Diagnostics Group, Dian Diagnostics Group, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Pathological Examination market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Pathological Examination Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Pathological Examination Market, Segmentation by Type:
Histopathology
Cytopathology
Immunohistochemical Pathology
Molecular Pathology
Global Pathological Examination Market, Segmentation by Application:
Hospital
Medical Laboratory
Companies Profiled:
Quest Diagnostics
Sonic Healthcare
Lab Corp
Unilabs
SYNLAB International
BML
Pathologists Diagnostic
StageBio
KingMed Diagnostics Group
Dian Diagnostics Group
Adicon Clinical Laboratories Inc.
Huayin Health
Key Questions Answered
1. How big is the global Pathological Examination market?
2. What is the demand of the global Pathological Examination market?
3. What is the year over year growth of the global Pathological Examination market?
4. What is the total value of the global Pathological Examination market?
5. Who are the Major Players in the global Pathological Examination market?
6. What are the growth factors driving the market demand?